Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com

Bipartisan Opioid Abuse Bill

In an effort to reverse the rapidly rising death toll from heroin, prescription drugs, and opioids across the U.S. which has recently risen to surpass automobile accidents as the leading cause of injury-related deaths according to the CDC, legislation has been drafted in a rare bipartisan effort.

The Comprehensive Addiction and Recovery Act (CARA)
Designed to strengthen prescription drug monitoring programs, better trace the diversion of opioid drugs, and increase promotion and access to addiction recovery services, CARA will also open up a variety of prevention and treatment avenues:

  • Prevention and […]
By |September 26th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Bipartisan Opioid Abuse Bill

Patient Engagement and Prescription Drug Label Enhancements

Upcoming improvements to prescription drug labeling are hoped to positively affect patient care across the board. Intentionally kept in the dark on the ingredients and indications of prescription drugs for well-over 100 years, the healthcare industry is shifting from the past’s blind trust to finally realizing today’s modern paradigm: Engaging patients as active participants in their own healthcare endeavors.

Small Label, Big Impact
Improving the synchronization between in-office care and home care, the FDA’s latest labeling procedures will not only help patients under a physician’s care better understand why each medication […]

By |September 12th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Patient Engagement and Prescription Drug Label Enhancements

How Common is Illegal Drug Use Among Pain Patients?

At the American Pain Society’s 35th Annual Scientific Meeting in Austin, findings were released on the use of illicit substances among chronic pain patients. Of 450,081 patients included in a study by Baltimore-based pain medication monitoring firm Ameritox, 10.4% of urine samples tested positive for the use of at least one illicit substance.

How Many of Those Identified Were Workers Comp Patients?
Workers compensation was the primary payer for 22,525 of the 450,081 patients in the study, conducted between January 2013 and July 2015, which showed the use of illicit substances […]

Putting the Injured Worker First

In the workman’s comp industry, significant effort is put toward breaking the pharmaceutical cost cycle for Payers. As the industry fights for savings, however, injured workers often get lost in the shuffle. The nameless and faceless many among worker’s comp injury statistics are quite removed from the system they rely upon.

Bottom Line Statistics Means Poor Outcomes for Injured Workers

As political pundits fight for special interests, benefit caps are set with no relation to each state’s average weekly wage, ignoring improved wage data and analytical methods that could mend take-home […]

By |June 15th, 2016|Drug Utilization Review, Medical Cost Containment, Workers Compensation Payers|Comments Off on Putting the Injured Worker First

Key Takeaways from a Recent National Safety Council Survey

Subsequent to the CDC’s new guidelines regarding the treatment of chronic pain, The National Safety Council (NSC) released its latest survey regarding doctor prescribing practices. Summarized below, the statistics

CDC Guidelines: Use non-opioid therapies first.
NSC Stats: 74% of doctors erroneously believe opioids (morphine, oxycodone) are the most effective way to treat pain.
The Missing Link: Research shows OTC pain meds (ibuprofen, acetaminophen) offer the most effective relief for acute pain.

CDC Guidelines: Do not use opioids for the routine treatment of chronic pain.
NSC Stats: 67% of doctors base there prescribing […]

By |May 15th, 2016|Drug Utilization Review, Medical Cost Containment, Pharmacotherapy Review|Comments Off on Key Takeaways from a Recent National Safety Council Survey
  • pharma cost management for large loss workers compensatino claims
    Permalink Gallery

    Effective Pharma Management Can Help Offset Increases in Prescription Costs

Effective Pharma Management Can Help Offset Increases in Prescription Costs

2015 saw rising drug prices contributing to the growth in pharmacy spending for American workers’ compensation payers. Meanwhile, opioid and compound drug cost management continues to be an Achilles heel. An effective pharma cost management program can offset these costs by aiming to improve pain treatment regimens for injured workers.

Pharmacotherapy Review Can Reduce Opioid Spend

Opioids continue to be the costliest class of medications for occupational injuries. To combat the rise in opioid utilization in chronic pain treatment of injured workers, ANS introduced a face-to-face and highly proactive approach to […]

By |April 1st, 2016|Drug Utilization Review, Medical Cost Containment, Pharmaceutical Cost Containment, Pharmacotherapy Review|Comments Off on Effective Pharma Management Can Help Offset Increases in Prescription Costs

Innovating Clinical Intervention

The lack of communication among treating physicians for injured workers has been a known deficit in large loss claims for some time. Professional liability insurance companies have recently issued statements concerning the trend of incomplete patient information, missing tests and poor communication among physicians resulting in lengthier recoveries and costly medical treatment regimens.

Current clinical intervention programs embraced by the industry merely scratch the surface of success as they focus solely on a patient’s medication therapy. The reality is that in […]

By |February 15th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Innovating Clinical Intervention

6 Ways Pain Management is Mismanaged

There is a significant body of evidence suggesting that many Americans suffer from chronic pain and much of that pain is inadequately or ineffectively treated. Particularly in the case of chronic pain treatment via opioid analgesics, proper chronic pain management is critical in determining whether opioids are used in a manner that is both medically appropriate and in compliance with regulations. Pain management is an important area of patient care that is integral to the practice of medicine, yet so often it is mismanaged. Here we review six most […]

By |January 30th, 2016|Drug Utilization Review, Medical Cost Containment, Opioid Abuse, Pharmacotherapy Review|Comments Off on 6 Ways Pain Management is Mismanaged
  • ANS Pharmacotherapy Reivew fights the nation's opioid epidemic
    Permalink Gallery

    Abuse Deterrent Opioids a New Era of Opioid Drug Development

Abuse Deterrent Opioids a New Era of Opioid Drug Development

The prevalence of opioid use and abuse has led to a new era of opioid drug development: Abuse deterrent (AD) opioids.

The goal?….

Maintain the efficacy of opioid formulations while improving their ability to deter abuse. Following guidelines developed by the FDA to categorize new opioid formulations, pharmaceutical companies are now on a quest to develop tomorrow’s safety net against opioid abuse.

How will the FDA be categorizing these new AD opioid formulations?

  1. Physical/chemical barriers
    Physical barriers that prevent the crushing, cutting, grating, grinding, or chewing of opioid formulations, alone or in combination […]

By |January 15th, 2016|Drug Utilization Review, Opioid Abuse, Pharmaceutical Industry|Comments Off on Abuse Deterrent Opioids a New Era of Opioid Drug Development
  • Steps to combat the opioid epidemic using ANS drug utilization review
    Permalink Gallery

    Strategies to Reduce Patient Reliance on Opioids Postoperatively

Strategies to Reduce Patient Reliance on Opioids Postoperatively

Surgeons across the nation are increasing efforts to reduce their overall use of opioids for the long term treatment of chronic pain post-operatively. The driving force- Curtailing the opioid abuse epidemic, an unfortunate but growing trend.

Well-Documented Risks
An epidemic effecting 5 million Americans, half of all opioid-related overdose deaths in the U.S. have been linked to prescription drugs – not “street” or “recreational” drugs. Opioid use, even short term, is particularly problematic for patients with a history of substance abuse.

Changing Practices
Seeing the effects of this epidemic, many surgeons are taking […]

By |December 30th, 2015|Drug Utilization Review, Medical Cost Containment, Opioid Abuse, Pharmacotherapy Review|Comments Off on Strategies to Reduce Patient Reliance on Opioids Postoperatively